The Cancer Foundation For The World » Pancreatic Cancer

Second AGA Foundation/Bernard Lee Schwartz Foundation Research Scholar Award Presented To Pancreatic Cancer Researcher

Jeff Daas — Fri, 30 Apr 2010 08:01:48 +0000

The American Gastroenterological Association (AGA) Foundation for Digestive Health and Nutrition (FDHN) announced this year’s recipient of the Bernard Lee Schwartz Foundation Research Scholar Award – Kenneth P. Olive, PhD. The $225,000 gift from the Bernard Lee Schwartz Foundation will provide Dr…
Read Full Article

Molecular Marker Could Help Spot Pancreatic Cancer Early

Jeff Daas — Wed, 28 Apr 2010 02:02:00 +0000

Researchers at the University of North Carolina at Chapel Hill School of Medicine have identified a molecular marker of pancreatic cancer that may help spot the disease at its earliest stages, when it can be treated more successfully with surgery…
Read Full Article

In Pancreatic Cancer, Is COX-2 Expression A Valuable Independent Prognostic Factor?

Jeff Daas — Thu, 22 Apr 2010 10:01:41 +0000

Cyclooxygenase-2 (COX-2) represents a key modulatory molecule in inflammation and carcinogenesis. COX-2 is known to have multiple tumorigenic effects. Increased expression of COX-2 has been observed in a variety of tumors including pancreatic cancer…
Read Full Article

New Molecular Therapy Candidates For Pancreatic Cancer

Jeff Daas — Thu, 22 Apr 2010 10:01:38 +0000

Insulin-like growth factor-I (IGF-I) is upregulated in human pancreatic cancer tissues but is not expressed in surrounding non-cancerous tissues. Serum level of IGF-I is elevated in pancreatic cancer patients. Histological analysis has shown that IGF-I receptor (IGF-IR) is positive in the membrane of pancreatic cancer tissues…
Read Full Article

Karmanos Cancer Institute Researchers Use Soy Derivative To Improve Pancreatic Cancer Treatment

Jeff Daas — Thu, 22 Apr 2010 10:01:34 +0000

Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit presented data at the American Association for Cancer Research’s 101st Annual Meeting 2010 that shows when genistein, a component of soy, is paired with the FDA-approved drug oxaliplatin, pancreatic cancer cells become more sensitive to chemotherapy…
Read Full Article

ABRAXANE(R) In Combination With Gemcitabine Increases Survival In First-Line Treatment Of Advanced Pancreatic Cancer In Phase I/II Study

Jeff Daas — Thu, 22 Apr 2010 10:01:30 +0000

Abraxis BioScience, Inc…
Read Full Article

New MicroRNA Technology Agreement Could Lead To Early Pancreatic Cancer Detection

Jeff Daas — Tue, 20 Apr 2010 06:00:46 +0000

The Translational Genomics Research Institute (TGen) and Asuragen Inc. have announced a research agreement that could lead to ways of detecting cancer before it spreads. TGen’s Dr…
Read Full Article

A New Technology Era: Personalized Medicine For Cancer Patients

Jeff Daas — Fri, 16 Apr 2010 13:00:08 +0000

Published online in Nature, a paper authored by over 200 members of the International Cancer Genome Consortium (ICGC) describes the beginnings of a Brave New World, a new era of personalised medicine for cancer patients…
Read Full Article

Artificial Pancreas Succeeds In Small Trial With Type 1 Diabetes Patients

Jeff Daas — Fri, 16 Apr 2010 00:00:05 +0000

In the first clinical trial of a system using two hormones, an artificial pancreas delivered insulin and glucagon in a way that closely mimics the body’s control of blood sugar and maintained near-normal levels of glucose in a small group of type 1 diabetes patients without them developing hypoglycemia…
Read Full Article

Artificial Pancreas Succeeds In Small Trial With Type 1 Diabetes Patients

Jeff Daas — Thu, 15 Apr 2010 23:00:12 +0000